| - Industry | - Sector | Mr. Seok-hwan Yoo CEO | KRX SM Exchange | - ISIN |
| South Korea Country | 74 Employees | - Last Dividend | - Last Split | - IPO Date |
Rokit Healthcare Inc. is a pioneering biotechnology company that focuses on hyper-personalized organ regenerative healthcare solutions. Established in 2012 and based in Seoul, South Korea, Rokit Healthcare is renowned for its innovative contributions to medical 3D bioprinting technology. The company specializes in advanced bioprinters and disposable medical device kits that are specifically designed for regenerative therapies. By combining cutting-edge technology with a deep understanding of regenerative medicine, Rokit Healthcare aims to transform treatment paradigms for chronic and degenerative diseases through personalized and autologous therapies.
Rokit Healthcare offers state-of-the-art bioprinters that enable the precise and efficient bioprinting of various tissues and organs. These machines are designed to support research and clinical applications in regenerative medicine, allowing for the production of customized biological structures tailored to individual patient needs.
These kits include all necessary tools and materials for conducting regenerative therapy procedures. Each kit is designed to ensure sterile conditions and ease of use, making it accessible for healthcare professionals to implement advanced regenerative techniques in their practices.
Rokit Healthcare provides specialized solutions for skin regeneration, particularly aimed at treating diabetic foot ulcers. These therapies leverage innovative materials and technologies to promote healing and tissue restoration, improving the quality of life for patients.
The company develops solutions targeting cartilage regeneration for osteoarthritis patients, focusing on restoring the cartilage architecture and function through innovative therapies that promote natural healing processes.
Rokit Healthcare addresses chronic kidney disease through advanced regenerative techniques. Their products are designed to facilitate the regeneration of kidney tissues, aiming to restore kidney function and enhance patient outcomes.
These biocompatible inks are essential for the 3D bioprinting process, allowing for the creation of complex tissue structures. Rokit Healthcare's bioinks are formulated to support cell viability, differentiation, and integration with existing tissues.
The company offers specialized media for the culture and expansion of human adult stem cells, crucial for regenerative therapies and research applications. These media are optimized to support the growth and maintenance of stem cell populations.
Rokit Healthcare develops advanced reconstructed human epidermis models used for drug testing and skin research. These models help researchers better understand skin biology and evaluate the effects of treatments before clinical applications.
The company explores the intersection of biotechnology and wellness by offering supplements aimed at promoting longevity and reducing the effects of aging. These products are formulated based on research in regenerative medicine and cellular health.